至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Inhibition of Ocular Tumor and Endothelial Cell Growth with a TEAD4216 Peptide Fragment

World Journal of Oncology Research. 2018; 
Bissan Ahmed, *, Andrew Stempel , Trevor J. McFarland , Bruce Ksander , Binoy Appukuttan and Tim Stout
Products/Services Used Details Operation
Peptide Synthesis A 26 amino acid sequence corresponding to a SerThr-Tyr domain within TEAD4216 (Figure 1), linked to a 10 amino acid cell importation signal (RMR) was synthesized (GenScript NJ). Human ocular melanoma cells (Mel 270, Mel 202; a kind gift from Dr Bruce Ksander), retinoblastoma cells (Y79; ATTC, MD), primate retina/choroid ocular endothelial cells (RF/6A; ATCC, MD) and human retinal pigment epithelial cells (ARPE19; ATCC, MD), (CRL 1500 breast cancer cell line; ATCC, MD) were plated into 96 well plates and cultured for 24 h. Recombinant STY-RMR peptide was added to the cell culture media at various concentrations (10 to 30 mg /100ml). Get A Quote

摘要

Purpose: Transcriptional enhancer factor 1-related (RTEF-1) also known as TEAD4 is expressed in ocular vascular endothelial cells and plays a role in the control of VEGF expression. Alternative processing of TEAD4 hnRNA results in different proteins able to stimulate or inhibit VEGF gene transcription. The purpose of this study is to test whether short peptide fragments (STY-RMR), representing functional domains of the inhibitory TEAD4216 isoform, can inhibit tumor as well as endothelial cell proliferation. Experimental Design: Cell proliferation was assessed using a colorimetric assay in cell lines incubated with STY-RMR, the amount of secreted VEGF within media was determined both in treated and control cell ... More

关键词